Toll Free: 1-888-928-9744

Global and China Drugs for Renal Cell Carcinoma Research Report to 2021

Published: Jun 22, 2016 | Pages: 118 | Publisher: QYResearch | Industry: Medical Devices | Report Format: Electronic (PDF)

The global Drugs for Treatment of Renal Cell Carcinoma market was valued at USD 26.4 Billion in 2015, and is projected to reach USD 35 Billion by 2021, at a CAGR of 5.81% between 2016 and 2021. Aging population leads to increase the prevalence of Renal Cell Carcinoma, polypharmacy rates rise, the expected drugs enter the market which is studying, and the market quickly absorb those drugs.

This report studies Drugs for Treatment of Renal Cell Carcinoma in Global and China market, focuses on price, sales, market share and revenue of each type in global China. This report also focuses on the sales (consumption), production and market share of Drugs for Treatment of Renal Cell Carcinoma in India and China, forecast to 2020, from 2015.

Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing nationwide hospital, in 2015 and 2016, covering 
Nexavar 
Votrient 
Inlyta 
Sutent 
Temsirolimus 
Everolimus Tablets

Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Renal Cell Carcinoma, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering 
Bayer 
Roche
Novartis Pharma
Wyeth 
Pfizer
GlaxoSmithKline
SP ACCURE Labs
Natco

Split by regions, this report focuses on the sales (consumption), market share, growth rate by manufacturer of Drugs for Treatment of Age-related Macular Degeneration in Europe and China, from 2011 to 2020 (forecast), covering 
Europe 
China

With 118 pages, 138 charts and eight chapters, to display the market present situation and future, clearly and deeply.


 
 Table of Content
Global and China Drugs for Renal Cell Carcinoma Research Report 2015-2021 1 Drugs for Treatment of Renal Cell Carcinoma Overview and Each Type 1.1 Product Overview of Drugs for Treatment of Renal Cell Carcinoma 1.1.1 Definition and Product Scope of Drugs for Treatment of Renal Cell Carcinoma 1.1.2 Global Market Size (Value and Volume) of Drugs for Treatment of Renal Cell Carcinoma 2015-2020 1.1.3 China Market Size (Value and Volume) of Drugs for Treatment of Renal Cell Carcinoma 2015-2020 1.2 Product Segments and Price of Each Type 1.2.1 Product Type of Key Manufacturers 1.2.2 Price List of Each Type in 2015 to 2016 1.2.3 Market Share and Growth Rate of Each Type 1.2.4 Nexavar Specification and Price in 2015 and 2016 1.2.5 Votrient Specification and Price in 2015 and 2016 1.2.6 Inlyta Specification and Price in 2015 and 2016 1.2.7 Sutent Specification and Price in 2015 and 2016 1.2.8 Temsirolimus Specification and Price in 2015 and 2016 1.2.9 Everolimus Tablets Specification and Price in 2015 and 2016 1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016 1.3.1 Price List (Interviewed) of Nexavar by Key Manufacturers 1.3.2 Price List (Interviewed) of Votrient by Key Manufacturers 1.3.3 Price List (Interviewed) of Inlyta by Key Manufacturers 1.3.4 Price List (Interviewed) of Sutent by Key Manufacturers 1.3.5 Price List (Interviewed) of Temsirolimus by Key Manufacturers 1.3.6 Price List (Interviewed) of Everolimus Tablets by Key Manufacturers 2 Competition Analysis by Manufacturers in Global and China 2.1 Global Market Drugs for Treatment of Renal Cell Carcinoma Sales and Share List of Key Manufacturers 2010 to 2015 2.2 Global Market Drugs for Treatment of Renal Cell Carcinoma Revenue and Share List of Key Manufacturers 2010 to 2015 2.3 Global Drugs for Treatment of Renal Cell Carcinoma Average Price List of Key Manufacturers 2010 to 2015 2.4 China Market Drugs for Treatment of Renal Cell Carcinoma Sales and Share List of Key Manufacturers 2010 to 2015 2.5 China Market Drugs for Treatment of Renal Cell Carcinoma Revenue and Share List of Key Manufacturers 2010 to 2015 2.6 China Drugs for Treatment of Renal Cell Carcinoma Average Price List of Key Manufacturers 2010 to 2015 3 Sales and Revenue Segments of Each Type 2015 to 2016 3.1 Global Sales and Revenue Segments of Each Type 2015 to 2016 3.1.1 Global Sales and Market Share of Each Type 2015 to 2016 3.1.2 Global Revenue and Market Share of Each Type 2015 to 2016 3.2 Nexavar Sales and Growth Rate 2015 to 2020 3.3 Votrient Sales and Growth Rate 2015 to 2020 3.4 Inlyta Sales and Growth Rate 2015 to 2020 3.5 Sutent Sales and Growth Rate 2015 to 2020 3.6 Temsirolimus Sales and Growth Rate 2015 to 2020 3.7 Everolimus Tablets Sales and Growth Rate 2015 to 2020 4 Market Segments and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015-2020 4.1.1 Sales and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015-2020 4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 4.2 Price and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 4.2.1 Price and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 4.2.2 Price Growth Rate Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 4.3 China Market Forecast to 2020 4.3.1 China Sales and market share of Drugs for Treatment of Renal Cell Carcinoma 2015 to 2020 4.4 India Market Forecast to 2020 4.4.1 India Sales and market share of Drugs for Treatment of Renal Cell Carcinoma 2015 to 2020 5 Raw Materials and Applications 5.1 Key Raw Materials and Price Analysis for Nexavar 5.1.1 Key Raw Materials for Nexavar 5.1.2 Price Forecast of Key Raw Materials for Nexavar 2016 to 2021 5.2 Key Raw Materials and Price Analysis for Votrient 5.2.1 Key Raw Materials for Votrient 5.2.2 Price Forecast of Key Raw Materials for Votrient 2016 to 2021 5.3 Key Raw Materials and Price Analysis for Inlyta 5.3.1 Key Raw Materials for Inlyta 5.3.2 Price Forecast of Key Raw Materials for Inlyta n 2016 to 2021 5.4 Key Raw Materials and Price Analysis for Sutent 5.4.1 Key Raw Materials for Sutent 5.4.2 Price Forecast of Key Raw Materials for Sutent 2016 to 2021 5.5 Key Raw Materials and Price Analysis for Temsirolimus 5.5.1 Key Raw Materials for Temsirolimus 5.5.2 Price Forecast of Key Raw Materials for Temsirolimus 2016 to 2021 5.6 Key Raw Materials and Price Analysis for Everolimus Tablets 5.6.1 Key Raw Materials for Everolimus Tablets 5.6.2 Price Forecast of Key Raw Materials for Everolimus Tablets 2016 to 2021 6 Key Manufacturers Analysis of Drugs for Treatment of Age-related Macular Degeneration 6.1 Bayer 6.1.1 Company Basic Information 6.1.2 Nexavar (Specification and Price) 6.1.2.1 Nexavar 0.2g, Price, Sales Value and Market Share of Bayer 6.1.3 Sales Value, Gross Margin 2011-2016 6.1.3.1 Sales Value, Gross Margin and Growth rate of Bayer Nexavar 0.2g 6.1.4 Interviewee, Name and Contact 6.2 Natco 6.2.1 Company Basic Information 6.2.2 Nexavar (Specification and Price) 6.2.2.1 Nexavar 0.2g, Price, Sales Value and Market Share of Natco 6.2.3 Sales Value, Gross Margin 2011-2016 6.2.3.1 Sales Value, Gross Margin and Growth rate of Natco Nexavar 0.2g 6.2.4 Interviewee, Name and Contact 6.3 GlaxoSmithKline 6.3.1 Company Basic Information 6.3.2 Votrient (Specification and Price) 6.3.2.1 Votrient 200mg*30T, Price, Sales Value and Market Share of GlaxoSmithKline 6.3.3 Sales Value, Gross Margin 2011-2016 6.3.3.1 Sales Value, Gross Margin and Growth rate of GlaxoSmithKline Votrient 200mg*30T 6.3.4 Interviewee, Name and Contact 6.4 Pfizer 6.4.1 Company Basic Information 6.4.2 Inlyta (Specification and Price) 6.4.2.1 Inlyta 1mg*28T, Price, Sales Value and Market Share of Pfizer 6.4.2.2 Inlyta 5mg*28T, Price, Sales Value and Market Share of Pfizer 6.4.3 Sales Value, Gross Margin 2011-2016 6.4.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Inlyta 1mg*28T 6.4.3.2 Sales Value, Gross Margin and Growth rate of Pfizer Inlyta 5mg*28T 6.4.4 Interviewee, Name and Contact 6.5 SP Accure Labs 6.5.1 Company Basic Information 6.5.2 Sutent (Specification and Price) 6.5.2.1 Sutent 12.5mg, Price, Sales Value and Market Share of SP Accure Labs 6.5.2.2 Sutent 25mg, Price, Sales Value and Market Share of SP Accure Labs 6.5.2.3 Sutent 50mg, Price, Sales Value and Market Share of SP Accure Labs 6.5.3 Sales Value, Gross Margin 2011-2016 6.5.3.1 Sales Value, Gross Margin and Growth rate of SP Accure Labs Sutent 12.5mg 6.5.3.2 Sales Value, Gross Margin and Growth rate of SP Accure Labs Sutent 25mg 6.5.3.1 Sales Value, Gross Margin and Growth rate of SP Accure Labs Sutent 50mg 6.5.4 Interviewee, Name and Contact 6.6 Pfizer 6.6.1 Company Basic Information 6.6.2 Sutent (Specification and Price) 6.6.2.1 Sutent 12.5mg, Price, Sales Value and Market Share of Pfizer 6.6.2.2 Sutent 25mg, Price, Sales Value and Market Share of Pfizer 6.6.2.3 Sutent 50mg, Price, Sales Value and Market Share of Pfizer 6.6.3 Sales Value, Gross Margin 2011-2016 6.6.3.1 Sales Value, Gross Margin and Growth rate of Sutent 12.5mg 6.6.3.2 Sales Value, Gross Margin and Growth rate of Sutent 25mg 6.6.3.1 Sales Value, Gross Margin and Growth rate of Sutent 50mg 6.6.4 Interviewee, Name and Contact 6.7 Wyeth 6.7.1 Company Basic Information 6.7.2 Temsirolimus (Specification and Price) 6.7.2.1 Temsirolimus 1mg*10T, Price, Sales Value and Market Share of Wyeth 6.7.3 Sales Value, Gross Margin 2011-2016 6.7.3.1 Sales Value, Gross Margin and Growth rate of Wyeth Temsirolimus 1mg*10T 6.7.4 Interviewee, Name and Contact 6.8 Pfizer 6.8.1 Company Basic Information 6.8.2 Temsirolimus (Specification and Price) 6.8.2.1 Temsirolimus 1mg*10T, Price, Sales Value and Market Share of Pfizer 6.8.3 Sales Value, Gross Margin 2011-2016 6.8.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Temsirolimus 1mg*10T 6.8.4 Interviewee, Name and Contact 6.9 Novartis Pharma 6.9.1 Company Basic Information 6.9.2 Everolimus Tablets (Specification and Price) 6.9.2.1 Everolimus Tablets 2.5mg, Price, Sales Value and Market Share of Novartis Pharma 6.9.2.2 Everolimus Tablets 5mg, Price, Sales Value and Market Share of Novartis Pharma 6.9.3 Sales Value, Gross Margin 2011-2016 6.9.3.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Everolimus Tablets 2.5mg 6.9.3.2 Sales Value, Gross Margin and Growth rate of Novartis Pharma Everolimus Tablets 5mg 6.9.4 Interviewee, Name and Contact 7 Technology Development Trend 7.1 Manufacturing Process of Drugs for Treatment of Erectile Dysfunction 7.2 Analysis of Manufacturing Process 7.3 Development Trend 8 Worldwide, an estimated time for the drug in Erectile Dysfunction research to market 9 Patent expiration time analysis 9.1 Viagra patent expires in China and sales 9.2 Cialis patent expires in China and sales 9.3 Levitra patent expires in China and sales 10 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Drugs for Treatment of Renal Cell Carcinoma Figure Global Market Size (Value) of Drugs for Treatment of Renal Cell Carcinoma 2015-2020 Figure Global Market Size (Volume) of Drugs for Treatment of Renal Cell Carcinoma 2015-2020 Figure China Market Size (Value) of Drugs for Treatment of Renal Cell Carcinoma 2015-2020 Figure China Market Size (Volume) of Drugs for Treatment of Renal Cell Carcinoma 2015-2020 Table Product Type of Key Manufacturers Table Price List of Each Type Table Market Share of Each Type Figure Growth Rate of Each Type 2015 to 2016 Figure Picture of Nexavar Table Specification and Price of Nexavar in 2015 and 2016 Figure Picture of Votrient Table Specification and Price of Votrient in 2015 and 2016 Figure Picture of Inlyta Table Specification and Price of Inlyta in 2015 and 2016 Figure Picture of Sutent Table Specification and Price of Sutent in 2015 and 2016 Figure Picture of Temsirolimus Table Specification and Price of Temsirolimus in 2015 and 2016 Figure Picture of Everolimus Tablets Table Specification and Price of Everolimus Tablets in 2015 and 2016 Table Price List (Interviewed) of Nexavar by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Votrient by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Inlyta by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Sutent Tablets by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Temsirolimus Tablets by Key Manufacturers in 2015 and 2016 Table Price List (Interviewed) of Everolimus Tablets by Key Manufacturers in 2015 and 2016 Table Global Market Drugs for Treatment of Renal Cell Carcinoma Sales List of Key Manufacturers 2010 to 2015 Table Global Market Drugs for Treatment of Renal Cell Carcinoma Sales Share List of Key Manufacturers 2010 to 2015 Table Global Market Drugs for Treatment of Renal Cell Carcinoma Revenue List of Key Manufacturers 2010 to 2015 Table Global Market Drugs for Treatment of Renal Cell Carcinoma Revenue Share List of Key Manufacturers 2010 to 2015 Table Global Drugs for Treatment of Renal Cell Carcinoma Average Price List of Key Manufacturers 2010 to 2015 Table China Market Drugs for Treatment of Renal Cell Carcinoma Sales List of Key Manufacturers 2010 to 2015 Table China Market Drugs for Treatment of Renal Cell Carcinoma Sales Share List of Key Manufacturers 2010 to 2015 Table China Market Drugs for Treatment of Renal Cell Carcinoma Revenue List of Key Manufacturers 2010 to 2015 Table China Market Drugs for Treatment of Renal Cell Carcinoma Revenue Share List of Key Manufacturers 2010 to 2015 Table China Drugs for Treatment of Renal Cell Carcinoma Average Price List of Key Manufacturers 2010 to 2015 Table Global Sales of Each Type 2015 to 2016 Table Global Sales Market Share of Each Type 2015 to 2016 Table Global Revenue of Each Type 2015 to 2016 Table Global Revenue Market Share of Each Type 2015 to 2016 Figure Nexavar Sales and Growth Rate 2015 to 2020 Figure Votrient Sales and Growth Rate 2015 to 2020 Figure Inlyta Sales and Growth Rate 2015 to 2020 Figure Sutent Sales and Growth Rate 2015 to 2020 Figure Temsirolimus Sales and Growth Rate 2015 to 2020 Figure Everolimus Tablets Sales and Growth Rate 2015 to 2020 Table Sales and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015-2020 Figure Sales Growth Rate Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 Table Price and Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 Figure Price Growth Rate Forecast of Drugs for Treatment of Renal Cell Carcinoma by Regions 2015 to 2020 Table China Sales and market share of Drugs for Treatment of Renal Cell Carcinoma 2015 to 2020 Table India Sales and market share of Drugs for Treatment of Renal Cell Carcinoma 2015 to 2020 Table Key Raw Materials for Nexavar Table Price Forecast of Key Raw Materials for Nexavar Table Key Raw Materials for Votrient Table Price Forecast of Key Raw Materials for Votrient Table Key Raw Materials for Inlyta Table Price Forecast of Key Raw Materials for Inlyta Table Key Raw Materials for Sutent Table Price Forecast of Key Raw Materials for Sutent Table Key Raw Materials for Temsirolimus Table Price Forecast of Key Raw Materials for Temsirolimus Table Key Raw Materials for Everolimus Tablets Table Price Forecast of Key Raw Materials for Everolimus Tablets Table Bayer Basic Information List Table Natco Basic Information List Table GlaxoSmithKline Basic Information List Table Pfizer Basic Information List Table SP Accure Labs by Share Ltd Basic Information List TablePfizer Basic Information List Table Wyeth Basic Information List Table Pfizer Basic Information List Table Novartis Pharma Basic Information List



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...
Choose License Type
Single User - US $2350
Multi User - US $4700
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify